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Abstract
Background: Currently, there still is no treatment that eliminates tinnitus in all patients. Recent studies have shown
that Tinnitus Retraining Therapy (TRT) significantly improves quality of life for tinnitus patients. Also, several studies
have reported that transcranial Direct Current Stimulation (tDCS) has a positive effect on attention, working memory,
long-term memory and other cognitive processes. The aim of this randomised placebo-controlled double-blind study
is to evaluate the added effect of tDCS to TRT in chronic tinnitus patients. To our knowledge, this is the first study to
combine both methods.
Methods: Patients with chronic, non-pulsatile tinnitus will be randomised in two treatment groups: TRT and real
tDCS versus TRT and sham tDCS. Evaluations will take place at baseline before therapy starts, at the end of the
TRT and 3 months after therapy starts. The Tinnitus Functional Index will be used as the primary outcome measurement.
Secondary outcome measurements will be the Visual Analogue Scale of Loudness, Hospital Anxiety and Depression Scale
(HADS), Hyperacusis Questionnaire, psychoacoustic measurements and Event-related potential (ERP).
Discussion: To our knowledge this is the first study to combine TRT and tDCS. The objective is to evaluate whether
tDCS can provide faster and/or more relief from the annoyance experienced in chronic tinnitus patients’ daily
lives. The advantage of the study is that it is double-blind and placebo-controlled.
Trial registration: The present study protocol was registered on 31 October 2014 at Clinicaltrials.gov: NCT02285803.
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Background
Tinnitus is the perception of sound without the occur-
rence of a corresponding external sound source. Ap-
proximately 25.3 % of the US population experience
some tinnitus and 7.9 % suffer from frequent tinnitus
[1]. Currently, there is still no treatment that totally
eliminates tinnitus in all patients. Therefore, the goal is
to change the reaction to tinnitus and thus reduce the
impact of tinnitus on the patient’s daily life. The type
of counselling that tries to achieve this goal is called
Tinnitus Retraining Therapy (TRT). Early studies have
shown that 82 % respond positively to TRT [2]. TRT is
comprised of two components: counselling and sound
enrichment. Counselling is a one-on-one conversation
between the patient and the audiologist or counsellor.
A family member may be involved at the patient’s
request. The counselling is based on the Jastreboff
neurophysiological model [3]. Counselling will educate the
patient on the working mechanism of the ear and tinnitus
and promote adaptive coping behaviours. The second im-
portant aspect of TRT is sound enrichment. This can be
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achieved through a noise masker or even background
noise in the environment. Sound enrichment results in
partial or complete masking of the tinnitus, allowing
the patient to ignore or transfer it to the subconscious.
Philips et al. (2010) emphasised the importance of using
low-level noise instead of completely masking the tinnitus
to achieve down-regulation [4].
Transcranial Direct Current Stimulation (tDCS) is a
form of neuromodulation in which a low current is ap-
plied to the brain by means of two electrodes: the anode
placed on the dysfunctional site and the cathode placed
on a ‘silent’ part of the body. Nowadays, mostly bifrontal
tDCS is applied in tinnitus patients with the anode and
cathode placed on the right and left dorsolateral prefrontal
cortex (DLPFC) respectively. However, Martin et al. sug-
gested placing the cathode on the right upper arm and the
anode on the left DLPFC to prevent cathode-related in-
hibitory effects at the cortical site [5]. Research has shown
that tDCS can provide temporary relief from tinnitus in
39.5 % of tinnitus patients [6]. In addition, previous studies
have shown that tDCS has a beneficial effect on numerical
competence [7] and working memory in depressed per-
sons [8]. It also has also been reported beneficial to learn-
ing and memory in persons with a brain injury [9].
The aim of the present study is to evaluate the additive
effect of tDCS to TRT. The idea is that tDCS would
prime the central nervous system and thus create a
stronger and faster learning effect for coping with tin-
nitus. This setup was based on the research of Martin et
al. [10]. Their research showed that performance on a
cognitive task could be improved by giving tDCS during
the task [10]. The timing of tDCS was also found to be
important. Furthermore, Martin et al. [11] found that
tDCS simultaneously presented with a cognitive training
task led to better within-session skill, with a significant
difference found between conditions the following day
when compared to presentation of tDCS prior to the
cognitive training. Therefore, Martin et al. suggested the
combination of tDCS with a rehabilitation protocol to
improve the effect of the protocol [11].
Methods
The present study is a randomised placebo-controlled
double-blind trial in order to find out if tDCS adds value
to TRT in chronic tinnitus patients. Patients will be re-
ferred by the ear, nose and throat (ENT) department of
the Antwerp University Hospital and will be randomised
in group A (real tDCS) or group B (sham tDCS).
Ethics
Written consent will be obtained from every patient.
The study protocol was approved by the ethical committee
of the Antwerp University Hospital on 27 October 2014
with protocol number EC14/40/406 (Clinaltrials.gov:
NCT02285803).
Inclusion and exclusion criteria
The patient must meet specific criteria during consult-
ation with the ENT before inclusion and randomisation.
The appropriate examinations will be performed to make
sure the patients meet the exclusion and inclusion criteria.
During the study, the patient has the right to leave the
study at any time. The occurrence of severe adverse events
also can lead to discontinuation of the study.
The inclusion criteria are as follows:
 Duration of (worsening of) tinnitus between
3 months and 4 years
 Minimum age of the patient is 18 years old
 Maximum loudness of tinnitus on the Visual
Analogue Scale (VAS) ≥ 4
 Tinnitus Functional Index (TFI) score ≥ 25
A patient is excluded from the study for the following
reasons:
 Pulsatile tinnitus
 Auditory thresholds > 70 decibels hearing level
(dBHL)
 Pregnancy
 Treatment of psychiatric disorder by a psychiatrist
 Pacemaker or defibrillator
 Acoustic neuroma




 Change of medication use
Study protocol
Tinnitus Retraining Therapy
Every patient will receive approximately six sessions of
TRT. The number of sessions will be adjusted to the needs
of each patient. The TRT will consist of counselling and
adjustment of a noise masker. The patient can try the
noise masker at home for 3 months without purchase
commitment. During counselling the patient will be edu-
cated on the working mechanism of the ear and tinnitus
and also learn some coping strategies to deal better with
sleeping and concentrations problems.
Transcranial Direct Current Stimulation (tDCS)
During every TRT session, the patient will receive tDCS
during the counselling. There are two groups: one will
receive ‘real’ tDCS and the other will receive ‘sham’
tDCS. The latter is the placebo group. Direct current is
transferred by means of 2 saline-soaked pairs of surface
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sponge electrodes (35 cm3) and delivered by a specially
developed, battery-driven, constant current neuroConn
stimulator (neuroConn, Ilmenau, Germany) with a max-
imum output of 10 mA. The anode (positive electrode)
will be placed on the right DLPFC (Brodmann area 9/46),
and the cathode (negative electrode) will be placed on the
left upper arm according to the 10–20 international sys-
tem for electroencephalogram (EEG) electrode placement.
The extracephalic placement of the cathode was chosen
because of the reduced risk of current flowing from one
electrode to the other, and as a consequence, the actual
current could stimulate a deeper and wider brain area. Set-
tings for both groups are described in Table 1. For the
‘real’ tDCS group, a constant current of 2 mA will be ap-
plied for 20 minutes with a fade-in and fade-out of 10 s.
The ‘sham’ tDCS group will receive a tDCS session of only
10 s with a current of 1 mA. Patients in the sham group
will experience the same tingling effect at the beginning of
the tDCS as those in the real tDCS group, but no real
stimulation will take place. Both the patient and investiga-
tor are blinded to the intervention type due to a five-digit
code that can be entered in the study mode of the tDCS
device that will be encoded sham or active tDCS stimula-
tion. The five-digit codes were randomised and supervised
by a third party.
Side effects
Possible side effects of tDCS are itching or tingling sensa-
tion, headache or fatigue and local burns at the position of
the electrodes [12].
Outcome measurements
There will be 3 test moments during the trial: before the
start of therapy (T0), after the counselling sessions (T1)
and after 84 days (T2). The primary outcome measure-
ments will be assessed at every test moment. However, the
secondary outcome measurements will only be assessed at
T0 and T2 (Table 2). We are interested in the difference
in the amount of change between both groups and the
percentage of responders in each group.
In order to categorise our patient group, all subjects
will undergo an audiometric hearing test according to
current clinical standards (International Organisation for
Standardisation (ISO) 8253–1:2010) with a 2-channel
Interacoustics AC 40 (Interacoustics A/S, Middelfart,
Denmark) in a soundproof audiometric booth. The
TDH-39 headphone is used as transducer to measure
air conduction thresholds of frequencies ranging from
125 Hz to 8 kHz. If thresholds exceeding 20 dBHL are
found, bone conduction thresholds will be determined
within a range of 250 Hz to 4 kHz.
Primary outcome measurement
Tinnitus Functional Index (TFI)
The TFI is a self-reported questionnaire, consisting of 25
questions, which examines the impact of tinnitus on pa-
tients’ daily lives. The patient answers each question on
a Likert scale ranging from 0 to 10. Questions 1 and 3
are expressed in percentages, and the Likert scale ranges
from 0 % to 100 %. The total score is calculated with the
mean of all questions. The answers are converted and
the total score is expressed as a number between 0 and
100. In addition to the total score, the score of eight sub-
scales can be determined. The subscales are the follow-
ing: intrusiveness, reduced sense of control, cognitive
interference, sleep disturbance, auditory difficulties at-
tributed to tinnitus, interference with relaxation, reduced
quality of life and emotional distress [13, 14].
Secondary outcome measurements
Visual Analogue Scale (VAS) of loudness
The patient scores the mean and maximum loudness of
their tinnitus on a scale of 0 (absence of tinnitus) to 10
(as loud as possible, cannot be any louder).
Hospital Anxiety and Depression Scale (HADS)
The HADS consists of 14 questions that assess anxiety
and depression. The patient can choose between four
answer options for each question. The score for both
components is a summation of the scores of all the
questions belonging to the subscale. A result greater than
Table 1 Settings for real Transcranial Direct Current Stimulation
(tDCS) and sham tDCS
Real tDCS Sham tDCS
Current 2 mA 1 mA
Fade in/out 10 s 10 s
Duration 1200 s 10 s
The settings of tDCS are chosen so the patient would not notice a difference
and they are blinded for the fact that they are randomised in the placebo or
the real treatment group
Table 2 Timing of outcome measurements
T0 T1 T2
Primary outcome measurements TFI x x x
Secondary outcome
measurements
VAS x x x
HQ x x x
DS14 x
PGIC x





DS14 14-item questionnaire assessing for type D-personality, HQ Hyperacusis
Questionnaire, ERP Event-related Potential, PGIC Patient Global Impression of
Change, TFI Tinnitus Functional Index, VAS Visual Analogue Scale
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8 suggests the presence of a depression and/or anxiety
disorder [15, 16].
Hyperacusis Questionnaire (HQ)
The HQ is a 14-item questionnaire that surveys a pa-
tient’s hypersensitivity to sound. There are four answer
options for every question: ‘no’, ‘yes a little’, ‘yes quite a
lot’ and ‘yes a lot’. A score of 28 is the cut-off for auditory
hypersensitivity [17, 18].
Patient Global Impression of Change (PGIC)
The PGIC assesses the patient’s perceived improvement
in the severity of the tinnitus as a result of the therapy.
The patient’s response options are the following: ‘very
much improved’, ‘much improved’, ‘minimally improved’,
‘unchanged’, ‘minimally worse’, ‘much worse’ and ‘very
much worse’.
DS14
The DS14 is a 14-item questionnaire that assesses the
presence of a type-D personality. Half the items refer to
negative affectivity and the other half refer to social in-
hibition. A score above or equal to 10 (range 0–28) on
both scales classifies a person as a type-D personality
[19]. The DS14 will be administered once at baseline be-
fore the start of therapy.
Psychoacoustic measurements
Psychoacoustic characteristics, such as frequency of tin-
nitus, loudness of tinnitus and minimal masking level
(MML) will be determined. The frequency of tinnitus
will be determined by means of frequency matching.
The patient may choose between two presented tones or
noises until a tone or noise is found that is similar to the
patient’s tinnitus. In case of unilateral tinnitus, the
contralateral ear is used as the test ear for frequency
matching. In case of bilateral tinnitus, the tones will be
presented in the ipsilateral ear. Furthermore, the loud-
ness matching will be determined by comparison of the
tinnitus to an external 1-kHz pure tone in the ipsilateral
ear. Finally, the MML (i.e., the lowest level of broadband
noise necessary to mask the tinnitus) will be determined
in the ipsilateral ear.
ERP
The event-related potential (ERP) is used to assess the
processing of sensory information. The ERP component
P300 is elicited by the oddball paradigm whereby the pa-
tient has to count the number of rare stimuli (2 kHz)
that are presented randomly between frequent stimuli
(1 kHz) at an intensity of 70 decibels sound pressure
level (dBSPL) with a ratio of respectively 20/80 %. The
stimuli used is a tone-burst with rise/fall time of 10 ms
and a plateau of 30 ms with a stimulus rate of 1.1/s.
Silver/Silver Chloride electrodes are placed according to
Standard International Electrode System rule 10–20 on
the vertex (Cz), frontal (Fpz) and on the ipsilateral mas-
toid. The Bio-logic Navigator Pro (Natus, Pleasanton,
USA) will be used to measure the ERPs.
Statistical methods
Data will be analysed with SPSS statistical software version
20 (SPSS Inc., Chicago, IL, USA). Descriptive analyses as
means and standard deviations will be used to describe
the characteristics of the participants. To compare the re-
sults of both intervention arms, repeated measures will be
computed if the data is normally distributed. If it is not,
the data will be logarithmically transformed first. The out-
come measurements will be set as dependent variables;
the intervention group (sham versus real) and test mo-
ment (T0, T1, T2) are the independent variables. The
interaction between test moment, intervention group
and hearing thresholds on the outcome measurements
will also be calculated. The significance level will be set
at p < 0.05. Furthermore, the percentage of responders
with a minimum reduction of 13 points on the TFI will
be calculated by descriptive analyses and also the confi-
dence interval of the observed difference.
Sample size calculation
Sample size was calculated using Glimmpse 2.0.0, an open
source online tool for calculating power and sample size.
The selected statistical test was the univariate approach to
repeated measures with Geisser-Greenhouse correction
with interactions between test moment (T0, T1, T2) and
group (real tDCS versus sham tDCS) and the TFI as out-
come measurement. A reduction of 13 points is consid-
ered the minimum to obtain a meaningful reduction in
TFI outcome scores. To measure improvement, the effect
size of the TFI is moderate to high [13]. Based on this in-
formation, an overall sample size of 24 was needed to
reach a desired power of 0.8, assuming a type-I error rate
of 0.05 and a standard deviation of 20.
Dissemination protocol
According to the Standard Protocol Items: Recommen-
dations for Interventional Trials (SPIRIT) guidelines, the
authors declare that data that break the blind will not be
presented prior to release of mainline results. Breaking
of the blind will occur at the end of the study. A clinical
article will be written on the primary and secondary out-
comes of the study and will be disseminated regardless
of the magnitude or direction of effect. The present trial
is not industry initiated; therefore, there are no publica-
tion restrictions imposed by sponsors. In addition, a full
study report, anonymised participant-level dataset and
statistical code for generating the results will be made
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publicly available no later than 3 years after termination
of the study for sharing purposes.
Discussion
Currently, there is no specific treatment to cure tinnitus
in all patients. Although tDCS is a known treatment for
tinnitus, it has shown only limited relief in 39.5 % of pa-
tients [6]. However, previous studies have shown that
TRT results in tinnitus relief for 82 % of the study popu-
lation [2]. This is a long-term process, and our goal of
this study is to evaluate if tDCS can provide faster and/
or more relief of the annoyance experienced in patients’
daily lives.
The advantage of the study is that it is double-blind
and placebo-controlled. The fact that we compare sham
and real tDCS will rule out the placebo effect of tDCS.
The study is also based on the literature: a recent study
showed that tDCS presented simultaneously with a cog-
nitive training task led to better within-session skill, with
a significant difference found between conditions the fol-
lowing day when compared to presentation of tDCS
prior to the cognitive training. The authors suggested
combining tDCS with rehabilitation protocols [11]. To
our knowledge, this is the first study to combine both
study methods.
Trial status
To date, patient recruiting has started and the first pa-
tients will be randomised in the near future. The end
date of study will be December 2015.
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